Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis.


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
05 05 2022
Historique:
received: 21 04 2021
revised: 28 07 2021
pubmed: 18 9 2021
medline: 10 5 2022
entrez: 17 9 2021
Statut: ppublish

Résumé

To describe the development of an Environmental contextual factors (EF) Item Set (EFIS) accompanying the disease specific Assessment of SpondyloArthritis international Society Health Index (ASAS HI). First, a candidate item pool was developed by linking items from existing questionnaires to 13 EF previously selected for the International Classification of Functioning, Disability and Health (ICF) /ASAS Core Set. Second, using data from two international surveys, which contained the EF item pool as well as the items from the ASAS HI, the number of EF items was reduced based on the correlation between the item and the ASAS HI sum score combined with expert opinion. Third, the final English EFIS was translated into 15 languages and cross-culturally validated. The initial item pool contained 53 EF addressing four ICF EF chapters: products and technology (e1), support and relationship (e3), attitudes (e4) and health services (e5). Based on 1754 responses of axial spondyloarthritis patients in an international survey, 44 of 53 initial items were removed based on low correlations to the ASAS HI or redundancy combined with expert opinion. Nine items of the initial item pool (range correlation 0.21-0.49) form the final EFIS. The EFIS was translated into 15 languages and field tested in 24 countries. An EFIS is available complementing the ASAS HI and helps to interpret the ASAS HI results by gaining an understanding of the interaction between a health condition and contextual factors. The EFIS emphasizes the importance of support and relationships, as well as attitudes of the patient and health services in relation to self-reported health.

Identifiants

pubmed: 34534275
pii: 6371887
doi: 10.1093/rheumatology/keab653
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2054-2062

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Uta Kiltz (U)

Rheumatology Department, Rheumazentrum Ruhrgebiet, Herne, Germany.
Medical School, Ruhr-Universität Bochum, Bochum, Germany.

Annelies Boonen (A)

Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, the Netherlands.
Faculty of Health Life Sciences and Medicine, Care and Public Health Research Institute (CAPHRI), Research line Functioning, rehabilitation and Participation, Maastricht University, Maastricht, the Netherlands.

Désirée van der Heijde (D)

Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.

Wilson Bautista-Molano (W)

Rheumatology Department, University Hospital Fundación Santa Fe de Bogotá, and School of Medicine, Universidad El Bosque, Bogotá, Colombia.

Ruben Burgos Vargas (R)

Department of Rheumatology, Hospital General de Mexico Universidad Nacional Autónoma, Mexico.

Praveena Chiowchanwisawakit (P)

Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Bassel El-Zorkany (B)

Rheumatology Department, Cairo University, Cairo, Egypt.

Inna Gaydukova (I)

Depatrment of therapy and rheumatology, North-Western Medical University, St Petersburg, Russia.

Pal Geher (P)

Department of Rheumatology, Semmelweis University, Budapest, Hungary.

Laure Gossec (L)

Department of Rheumatology, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris France.
Rheumatology Department, Pitié-Salpêtrière Hospital, AP-HP Sorbonne Université, Paris, France.

Michele Gilio (M)

Department of Internal Medicine, 'San Carlo' Hospital Potenza and Madonna Delle Grazie Hospital of Matera, Potenza, Italy.

Simeon Grazio (S)

Department of Rheumatology, Physical and Rehabilitation Medicine, Sestre Milosrdnice University Clinical Center, Zagreb, Croatia.

Jieruo Gu (J)

Department of Rheumatology, University Guangzhou, Guangzhou, China.

Muhammad Asim Khan (MA)

Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Tae-Jong Kim (TJ)

Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea.

Walter P Maksymowych (WP)

Department of Medicine, University of Alberta, Edmonton, Canada.

Helena Marzo-Ortega (H)

Department of Rheumatology, NIHR Leeds Biomedical Research Centre, Chapel Allerton Hospital, Leeds, and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

Victoria Navarro-Compán (V)

Department of Rheumatology, IdiPaz, University Hospital La Paz, Madrid, Spain.

Salih Ozgocmen (S)

Department of Rheumatology, Istinye University, Medicalpark Gaziosmanpasa Hospital, Istanbul, Turkey.

Dimos Patrikos (D)

Department of Rheumatology, Metropolitan Hospital Piraeus, Piraeus, Greece.

Fernando Manuel Pimentel-Santos (FM)

Rheumatology Department, NOVA Medical School, Universidade Nova De Lisboa, Lisbon, Portugal.

John Reveille (J)

Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.

Michael Schirmer (M)

Department of Internal Medicine, Clinic II, Innsbruck Medical University, Innsbruck, Austria.

Simon Stebbings (S)

Department of Medicine, University of Otago, Dunedin School of Medicine, Dunedin, New Zealand.

Filip Van den Bosch (F)

Molecular Immunology and Inflammation unit, VIB Center for Inflammation Research, Ghent, Belgium.
Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.

Ulrich Weber (U)

Practice Buchsbaum, Department of Rheumatology, Schaffhausen, Switzerland.

Juergen Braun (J)

Rheumatology Department, Rheumazentrum Ruhrgebiet, Herne, Germany.
Medical School, Ruhr-Universität Bochum, Bochum, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH